Maternal Weight Gain in Gestational Diabetes Controlled by Metformin Versus Insulin
Status:
Completed
Trial end date:
2019-01-15
Target enrollment:
Participant gender:
Summary
Insulin has many disadvantages for mothers with GDM including the need to give injections,
frequent daily testing for monitoring, and risks of hypoglycemia, increase in appetite,
weight gain and high cost. Metformin, an oral biguanide, may be a more logical alternative to
insulin for women with GDM who are unable to cope with the increasing insulin resistance of
pregnancy.
This study aim to compare maternal weight gain during pregnancy in women with gestational
diabetes, treated by insulin versus metformin.